Results 21 to 30 of about 8,290,554 (306)

Factors leading to discontinuation of biologic therapy in patients with severe asthma

Journal of Asthma, 2021
Objective To assess patient- and physician-reported reasons for discontinuing biologic therapy among patients with severe asthma from a real-world US cohort. Methods This retrospective analysis surveyed US physicians and their patients with severe asthma
J. Silver, M. Bogart, N. Molfino, J. Siddall, M. Small, Matt Hanson, B. Hahn   +6 more
semanticscholar   +1 more source

Biological therapy of psoriasis

Indian Journal of Dermatology, 2010
The treatment of psoriasis has undergone a revolution with the advent of biologic therapies, including infliximab, etanercept, adalimumab, efalizumab, and alefacept. These medications are designed to target specific components of the immune system and are a major technological advancement over traditional immunosuppressive medications.
Sivamani Raja, Correa Genevieve, Ono Yoko, Bowen Michael, Raychaudhuri Siba, Maverakis Emanual   +5 more
openaire   +3 more sources

Practical update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPS) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis with Biologic Therapy.

Actas Dermo-Sifiliográficas, 2021
BACKGROUND AND OBJECTIVES A new, updated AEDV Psoriasis Group consensus document on the treatment of moderate to severe psoriasis was needed owing to the approval, in recent years, of a large number of new drugs and changes in the treatment paradigm ...
J. Carrascosa, L. Puig, I. B. Romero, L. Salgado-Boquete, E. del Alcázar, J. J. Andrés Lencina, D. Moreno, P. de la Cueva   +7 more
semanticscholar   +1 more source

Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.

PLoS ONE, 2017
This study assessed the occurrence of indicators for suboptimal biologic therapy among ulcerative colitis (UC) and Crohn's disease (CD) patients over time in the United States (US).
Haridarshan Patel, Trevor Lissoos, David T Rubin   +2 more
doaj   +1 more source

Biologic therapy and paradoxical reactions

Journal of IMIDs, 2022
Paradoxical reactions are defined as adverse effects that manifest as a de novo appearance or the exacerbation of a condition that commonly responds to a certain class of drug.
Guillermo J. Sánchez-Rodríguez, Anna López-Ferrer   +1 more
doaj   +1 more source

Legionellosis and biologic therapies [PDF]

Respiratory Medicine, 2014
Biologic therapies are widely used in inflammatory diseases, and they are associated to an increased infection risk, especially to granulomatous and intracellular infections such as Legionella.A review of the literature revealed 105 cases of Legionella pneumonia in patients taking biologic therapies.
Bodro, M., Carratala, J., Paterson, D. L.   +2 more
openaire   +5 more sources

Biologic Therapies for Severe Asthma

New England Journal of Medicine, 2022
Biologic Therapies for Severe Asthma Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden. This review discusses the mechanisms, efficacy, and safety of biologics for severe asthma.
Guy G. Brusselle, Gerard H. Koppelman
openaire   +3 more sources

Use and Switching of Biologic Therapy in Patients with Non-Radiographic Axial Spondyloarthritis: A Patient and Provider Survey in the United States

Rheumatology and Therapy, 2020
Introduction The Food and Drug Administration (FDA) approved certolizumab-pegol, the first biologic for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA), for use in the United States (US) in March of 2019.
Atul Deodhar, David Sandoval, Elizabeth Holdsworth, Nicola Booth, Theresa Hunter   +4 more
doaj   +1 more source

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update

British Journal of Dermatology, 2020
The overall aim of the guideline is to provide up-to-date, evidence-based recommendations on the use of biologic therapies targeting TNF (adalimumab, etanercept, certolizumab pegol, infliximab), IL12/23p40 (ustekinumab), IL17A (ixekizumab, secukinumab ...
C. Smith, Z. Yiu, T. Bale, A. Burden, L. Coates, W. Edwards, E. Macmahon, S. Mahil, A. Mcguire, R. Murphy, C. Nelson-Piercy, C. Owen, R. Parslew, O. Uthman, R. Woolf, L. Manounah, M. Ezejimofor, L. Exton, M. F. Mohd Mustapa   +18 more
semanticscholar   +1 more source

Biologic therapy of rheumatoid arthritis [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2009
Rheumatoid arthritis (RA) and juvenile idiopathic/rheumatoid arthritis (JIA) are chronic, inflammatory, systemic, auto-immune diseases characterized by chronic arthritis leading to progressive joint erosions.
Damjanov Nemanja, Vojinović Jelena
doaj   +1 more source